You should seek the advice of your veterinarian if your pet is ill as only he or she can correctly advise on the diagnosis and recommend the treatment that is most appropriate for your pet.

Abstract
1. Adrafmil is a novel vigilance promoting agent developed in France by Louis Lafon Laboratories. 

2. Adrafinil causes increased locomotion without producing stereotypical activity in canines tested in an open field study 

3. The effectiveness of a single treatment is long-lasting, and the effectiveness persists over repeated treatments. 

4. Acquisition of a size discrimination problem is enhanced by adrafinil. This may be linked to performance motivation. 

5. Adrafinil causes a long-lasting increase in high frequency electroencephalographic activity recorded from cortical electrodes. 

6. These results indicate that adrafinil is novel behavioral stimulant with cognitive enhancing potential. The underlying mechanisms of action are still unknown.

Reference

Prog Neuropsychopharmacol Biol Psychiatry 2000 Jul;24(5):709-26